Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

IMpower010: Atezolizumab after Chemo in Non-Small Cell Lung Cancer
Author
Howard (Jack) West, MD
Image
ASCO 2021 Lung Cancer Updates banner

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually)  to review information presented at ASCO and ESMO for 2021.  

For this series, the doctors discuss new trials for patients with NSCLC. In this video, the doctors discuss IMpower010, and Adjuvant Atezolizumab After Chemotherapy in Resected Stage I-IIIA NSCLC.  
 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora